z-logo
open-access-imgOpen Access
Response letter on Micromanagement of drug-resistant advanced gastrointestinal stromal tumors: regorafenib—new ammunition in battling exon 17 mutations
Author(s) -
ChunNan Yeh
Publication year - 2018
Publication title -
translational gastroenterology and hepatology
Language(s) - English
Resource type - Journals
ISSN - 2415-1289
DOI - 10.21037/tgh.2018.06.03
Subject(s) - regorafenib , medicine , exon , stromal cell , oncology , cancer research , mutation , stromal tumor , colorectal cancer , gene , cancer , genetics , biology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here
Accelerating Research

Address

John Eccles House
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom